Nanoliter Glucose Assay For Diabetics
$99,848R43FY2003DKNIH
Phoenix Bioscience, Inc., San Ramon CA
Investigators
Abstract
(Revised) Description: Phoenix Bioscience is developing enabling technologies for point-of-care diagnostic applications. The MEMS-based technology provides for a cost effective, one step, ease-of-use testing procedure. The product automates what traditionally has been a multi-step process of lancing, blood droplet formation, and sample collection. The system can be adapted to accommodate a variety of sensor types covering a wide range of diagnostic tests. The automation, increased speed, and higher sampling accuracy will dramatically improve the ease and reliability of "finger prick" blood tests.
View original record on NIH RePORTER →